SAB Biotherapeutics (SABS) Insider Trading & Ownership

$4.20
+0.19 (+4.74%)
(As of 04/26/2024 ET)

SAB Biotherapeutics (NASDAQ:SABS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
25.95%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$15,821.20
Number Of
Insiders Selling
(Last 12 Months)
0
Get SABS Insider Trade Alerts

Want to know when executives and insiders are buying or selling SAB Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SABS Insider Buying and Selling by Quarter

SAB Biotherapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/7/2023Eddie Joe SullivanCEOBuy1,740$0.88$1,531.20  
11/30/2023Michael KingCFOBuy5,000$0.90$4,500.00  
11/29/2023Samuel J ReichChairmanBuy11,000$0.89$9,790.00  
(Data available from 1/1/2013 forward)

SABS Insider Trading Activity - Frequently Asked Questions

Who is on SAB Biotherapeutics's Insider Roster?

The list of insiders at SAB Biotherapeutics includes Christine E Hamilton, Eddie Joe Sullivan, Michael King, and Samuel J Reich. Learn more on insiders at SABS.

What percentage of SAB Biotherapeutics stock is owned by insiders?

25.95% of SAB Biotherapeutics stock is owned by insiders. Learn more on SABS's insider holdings.

Which SAB Biotherapeutics insiders have been buying company stock?

The following insiders have purchased SABS shares in the last 24 months: Christine E Hamilton ($7,300.00), Eddie Joe Sullivan ($1,531.20), Michael King ($4,500.00), and Samuel J Reich ($9,790.00).

How much insider buying is happening at SAB Biotherapeutics?

Insiders have purchased a total of 27,740 SABS shares in the last 24 months for a total of $23,121.20 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:SABS) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners